Kobe, Japan

Masuo Yamaoka


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 53(Granted Patents)


Location History:

  • Hyogo, JP (1998)
  • Kobe, JP (2002 - 2006)

Company Filing History:


Years Active: 1998-2006

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Masuo Yamaoka

Introduction

Masuo Yamaoka is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with steroid C-lyase inhibitory activity. With a total of 6 patents to his name, Yamaoka's work has implications for the treatment of various cancers and related conditions.

Latest Patents

Yamaoka's latest patents include innovative compositions that target steroid C-lyase activity. One of his notable inventions is related to naphthalene derivatives, which are useful in preventing and treating primary cancer of malignant tumors, as well as their metastasis and recurrence. Another significant patent involves substituted thiazole derivatives bearing 3-pyridyl groups, which serve as pharmaceutical compositions for treating conditions such as prostatism and breast cancer.

Career Highlights

Throughout his career, Masuo Yamaoka has worked with prominent companies in the pharmaceutical industry, including Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His expertise in the field has allowed him to contribute to groundbreaking research and development efforts.

Collaborations

Yamaoka has collaborated with esteemed colleagues such as Tomohiro Kaku and Akihiro Tasaka. These partnerships have further enhanced his research and innovation capabilities.

Conclusion

Masuo Yamaoka's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex chemical compounds and their potential therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…